Cell and gene therapies yield a small volume of individualized product for each single patient. Loss of the shipment or damage to the transported goods have serious consequences for patients.

UV-protective single-use bags address a specific vulnerability in biopharmaceutical manufacturing, where UV exposure during production, storage, and cold chain logistics can compromise sensitive products.

Explore the risk factors in small-volume fluid management, learn where manual processes introduce variability, and find out how closed, pump-driven single-use systems can improve accuracy and consistency.

Discover how plasmid design, transfection protocols, and controlled freezing methods combine to address critical manufacturing challenges in lentiviral vector production for gene therapy applications.

Learn about the crucial role vectors play in delivering genes, types of non-viral vectors, the challenges with non-viral vectors in gene therapy, and the advantages of lipid-based nanoparticles.

Manual bottle filling can introduce significant risks, impacting accuracy, sterility, and compliance. Learn how automation can improve product quality, enhance patient safety, and increase efficiency.

Tired of manual manipulation risks in biopharmaceuticals? Discover how automated homogenization ensures consistent cell counts and concentration levels, improving patient safety and process reproducibility.

Explore best practices for cryopreserving small-volume advanced therapy medicinal products (ATMPs), emphasizing sterility, cell viability, and efficiency using innovative single-use systems and aseptic connectors.

Explore the challenges of adding cryoprotectants, how they can help reduce the effects of harmful conditions like ice crystals, and the need for future stability studies and substitutes for toxic CPAs.

Review important factors in cell viability and cell health and how this information is crucial to researchers and cGMP cell banking.